ALFA Filings
Every announcement, straight from the exchange
Every Amerise Biosciences other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
4 announcements with these filters
Amerise Biosciences Ltd filed its quarterly shareholding pattern for the quarter ended September 30, 2026, in compliance with SEBI regulatory requirements.
Amerise Biosciences Limited confirmed it does not fall under the Large Corporate category as per SEBI's debt issuance framework for the financial year ended March 31, 2026. Consequently, the company is not required to submit initial or annual disclosures under the specific SEBI circular.
Amerise Biosciences Limited (BSE: 531681) submitted a certificate confirming the non-applicability of the Annual Secretarial Compliance Report for FY 2025-26. The company is exempt under SEBI Regulation 15(2) as its paid-up capital and net worth remain below the prescribed thresholds of ₹10 Crore and ₹25 Crore, respectively.
Amerise Biosciences Limited submitted its quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the period ended March 31, 2026. The Registrar and Share Transfer Agent confirmed that no physical share certificates were received for dematerialization during the quarter.